Crossmark

CDCA5 overexpression is an Indicator of poor prognosis in patients with hepatocellular carcinoma (HCC)

Crossref DOI link: https://doi.org/10.1186/s12885-018-5072-4

Published Online: 2018-11-29

Published Print: 2018-12

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Tian, Yunhong

Wu, Jianlin

Chagas, Cristian

Du, Yichao

Lyu, Huan

He, Yunhong

Qi, Shouliang

Peng, Yong

Hu, Jiani
Funding

Funding for this research was provided by:

the Foundation of the Innovation Seeding Project of the Science & Technology Department of Sichuan Province (2017062)

the Cooperative Project of Nanchong City with North Sichuan Medical College (NSMC20170461)
License Information

Text and Data Mining valid from 2018-11-29
More Information

Article History

Received: 23 August 2018

Accepted: 9 November 2018

First Online: 29 November 2018

Ethics approval and consent to participate

: This retrospective study was approved by the ethics committee of Nanchong Central Hospital and was carried out in accordance with the 1975 Helsinki Declaration. Because of the anonymous nature of the data and the opt-out option disclosed on our institution’s homepage, the requirement for additional informed consent to participate in this study was deemed unnecessary.

: Not applicable.

: The authors declare that they have no competing interests.

: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.